THE DEVELOPMENT OF THE RATIONAL SCHEME FOR THE APPLICATION OF DERINAT EYE DROPS, 0.25%, IN THE COMBINED TREATMENT OF EXPERIMENTAL OPHTHALMOHERPES

E. R Stirmanova , A. I Shchipanova , L. A Katargina

Russian Pediatric Ophthalmology ›› 2012, Vol. 7 ›› Issue (2) : 46 -49.

PDF
Russian Pediatric Ophthalmology ›› 2012, Vol. 7 ›› Issue (2) : 46 -49. DOI: 10.17816/rpoj37486
Articles
research-article

THE DEVELOPMENT OF THE RATIONAL SCHEME FOR THE APPLICATION OF DERINAT EYE DROPS, 0.25%, IN THE COMBINED TREATMENT OF EXPERIMENTAL OPHTHALMOHERPES

Author information +
History +
PDF

Abstract

The authors report the results of the experimental evaluation of the efficacy of a new parmaceutical dosage form of derinat eye drops. The study was carried out using the experimental rabbit model of ophthalmoherpes. In the first series of experiments, the therapeutic efficacy of derinat eye drops, 0.25%, was compared with that of 3% zovirax eye ointment. It was shown that derinat produced a well-apparent therapeutic effect comparable with that of zovirax. The clinical efficacy of combined therapy with derinat and zovirax with different intervals between the applications of either preparation was estimated in the 2 nd and 3d series of experiments. It is concluded that it is important to strictly comply with the prescribed intervals (2 hours) between the applications of the tested medications.

Keywords

derinat eye drops / experimental investigations / herpetic keratitis

Cite this article

Download citation ▾
E. R Stirmanova, A. I Shchipanova, L. A Katargina. THE DEVELOPMENT OF THE RATIONAL SCHEME FOR THE APPLICATION OF DERINAT EYE DROPS, 0.25%, IN THE COMBINED TREATMENT OF EXPERIMENTAL OPHTHALMOHERPES. Russian Pediatric Ophthalmology, 2012, 7(2): 46-49 DOI:10.17816/rpoj37486

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Егоров Е.А., Сугоняева О.Ю. Клиническое применение препарата Деринат — Интернет-журнал «Офтальмология для всех» http://www.oftalm.ru/

[2]

Каплина Э.Н., Вайнберг Ю.П. Деринат — природный иммуномодулятор для детей и взрослых. 3-е изд. — М., 2007.

[3]

Кузин В.Б., Соколова Т.П. Послеоперационная иммунокоррекция деринатом препролиферативной диабетической ретинопатии после пенретинальной лазеркоагуляции // Казан. мед. журн. — 2009. Т. 90, № 4. — С. 575—577.

[4]

Майчук Ю.Ф. Вирусные заболевания глаз. — М., 1981.

[5]

Применение Дерината в офтальмологии: Пособие для практикующих врачей. 2-е изд. / Под ред. Э.Н. Каплиной, Н. О. Бажанова. — Тверь, 2008.

[6]

Щипанова А.И., Майчук Ю.Ф., Стирманова Е.Р. и др. Медико-биологическая оценка новой глазной лекарственной формы отечественного препарата Деринат // Рос. офтальмол. журн. — 2012. — Т. 5, № 2. С. 88.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

135

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/